X0609 4 2026-04-01 0001600033 e.l.f. Beauty, Inc. ELF 0001513988 AMIN TARANG false C/O E.L.F. BEAUTY, INC. 601 12TH STREET, SUITE 1400 OAKLAND CA 94607 true true Chief Executive Officer true Common Stock, $0.01 par value 2026-04-01 4 M 0 71000 26.84 A 151296 D Common Stock, $0.01 par value 2026-04-01 4 S 0 31630 62.439 D 119666 D Common Stock, $0.01 par value 2026-04-01 4 S 0 21250 62.9289 D 98416 D Common Stock, $0.01 par value 20326 I The Tarang Amin 2025 GRAT Common Stock, $0.01 par value 20326 I The Hirni Amin 2025 GRAT Common Stock, $0.01 par value 246822 I By Family Trust Common Stock, $0.01 par value 246822 I By Family Trust Common Stock, $0.01 par value 468532 I By Amin Family General Partnership Common Stock, $0.01 par value 40295 I By 2025 Family Trust I Common Stock, $0.01 par value 40295 I By 2025 Family Trust II Stock Option (Right to Buy) 26.84 2026-04-01 4 M 0 71000 0 D 2027-02-14 Common Stock 71000 142000 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025. The sales reported herein were made solely to cover tax liabilities in connection with the exercise of stock options. The Reporting Person otherwise retained the remaining shares from the exercise. Includes 80,255 restricted stock units. The transaction was executed in multiple trades in prices ranging from $61.75 to $62.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The transaction was executed in multiple trades in prices ranging from $62.75 to $63.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Fully vested and exercisable. /s/ Scott K. Milsten, Attorney-in-Fact for Tarang Amin 2026-04-02